VERU: Veru Inc. Stock

by  •  • Comments Off on VERU: Veru Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 200.54
Enterprise Value ($M) 175.63
Book Value ($M) 45.21
Book Value / Share 0.31
Price / Book 4.44
NCAV ($M) 18.55
NCAV / Share 0.13
Price / NCAV 10.81

Profitability (mra)
Return on Invested Capital (ROIC) -0.66
Return on Assets (ROA) n/a
Return on Equity (ROE) -2.33

Liquidity (mrq)
Quick Ratio 4.22
Current Ratio 4.72

Balance Sheet (mrq) ($M)
Current Assets 45.14
Assets 71.80
Liabilities 26.59
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 16.30
Operating Income -95.54
Net Income -93.09
Earnings Per Share Basic And Diluted n/a
Earnings Per Share Diluted n/a
Earnings Per Share Basic n/a

Cash Flow Statement (mra) ($M)
Cash From Operations -88.01
Cash from Investing 6.33
Cash from Financing 11.11

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
04-24 13G Millennium Management Llc 5.20
02-14 13G/A Perceptive Advisors Llc 3.80 -28.93
02-06 13G/A Frost Phillip Md Et Al 3.50 0.00
12-26 13G Adage Capital Partners Gp, L.l.c. 9.50
12-08 13G/A Morgan Stanley 4.20 -48.43
06-08 13G/A BlackRock Inc. 4.98 -5.01

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-05-08 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-04-01 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-04-01 10-K/A UNITED STATES ‎SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K/A (Amendment No. 1)
2023-12-08 10-K UNITED STATES ‎SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K
2023-11-15 10-Q/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q/A (Amendment No. 1)
2023-08-10 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-05-10 323,541 1,333,538 24.26
2024-05-09 389,578 1,993,155 19.55
2024-05-08 908,460 3,313,229 27.42
2024-05-07 559,998 513,896 108.97
2024-05-06 474,153 423,065 112.08

(click for more detail)

Similar Companies
UPXI – Upexi, Inc. VBIV – VBI Vaccines Inc.
VCNX – Vaccinex, Inc. VINC – Vincerx Pharma, Inc.
VIRI – Virios Therapeutics, Inc.


Financial data and stock pages provided by
Fintel.io